SynthesisFrontiers in oncology2022

Patients with melanoma treated with immune checkpoint inhibitors who had non-thyroid endocrine and skin immune-related adverse events have better prognosis: A systematic review and meta-analysis.

Qian Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.